Esteban Masuda
83Patents
10h-index
61Co-inventors
81Inventor score
Filing activity: Oct 3, 2001 → Apr 26, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8163902B2 | Prodrugs of 2,4-pyrimidinediamine compounds and their uses | Chemistry; Metallurgy | 32 | Active |
| US7915273B2 | Compositions and methods for inhibition of the JAK pathway | Chemistry; Metallurgy | 32 | Active |
| US7538108B2 | Prodrugs of 2,4-pyrimidinediamine compounds and their uses | Chemistry; Metallurgy | 32 | Active |
| US7989448B2 | Prodrugs of 2,4-pyrimidinediamine compounds and their uses | Chemistry; Metallurgy | 28 | Active |
| US7659280B2 | 2,4-pyrimidinediamine compounds for treating or preventing autoimmune diseases | Chemistry; Metallurgy | 18 | Active |
| US10815206B2 | RIP1 inhibitory compounds and methods for making and using the same | Chemistry; Metallurgy | 15 | Active |
| US8211888B2 | Prodrugs of 2,4-pyrimidinediamine compounds and their uses | Chemistry; Metallurgy | 15 | Active |
| US10975064B2 | RIP1 inhibitory compounds and methods for making and using the same | Chemistry; Metallurgy | 14 | Active |
| US7576053B2 | Methods and compositions for treating degenerative bone disorders | Human Necessities | 12 | Active |
| US8227455B2 | Methods of treating cell proliferative disorders | Human Necessities | 10 | Active |
| US8530466B2 | Use of 2,4-pyrimidinediamines for the treatment of atherosclerosis | Human Necessities | 9 | Active |
| US8710223B2 | Protein kinase C inhibitors and uses thereof | Chemistry; Metallurgy | 7 | Active |
| US9481654B2 | Compositions and methods for inhibition of the JAK pathway | Chemistry; Metallurgy | 6 | Active |
| US8785437B2 | Prodrugs of 2,4-pyrimidinediamine compounds and their uses | Chemistry; Metallurgy | 5 | Active |
| US8334297B2 | 2,4-pyrimidinediamine compounds for treatment of inflammatory disorders | Human Necessities | 5 | Active |
| US9321763B2 | Protein kinase C inhibitors and uses thereof | Chemistry; Metallurgy | 5 | Active |
| US9566278B2 | Protein kinase C inhibitors and uses thereof | Emerging Cross-Sectional Technologies | 5 | Active |
| US8053434B2 | Kinase inhibitors and their uses | Chemistry; Metallurgy | 4 | Active |
| US9181222B2 | Protein kinase C inhibitors and uses thereof | Chemistry; Metallurgy | 3 | Active |
| US9593082B2 | Compositions and methods for inhibition of the JAK pathway | Chemistry; Metallurgy | 3 | Active |
| US9913843B2 | Protein kinase C inhibitors and uses thereof | Chemistry; Metallurgy | 3 | Active |
| US9682976B2 | Protein kinase C inhibitors and uses thereof | Chemistry; Metallurgy | 3 | Active |
| US6979549B2 | Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a CLLD8 protein | Emerging Cross-Sectional Technologies | 3 | Expired |
| US9169249B2 | Protein kinase C inhibitors and uses thereof | Emerging Cross-Sectional Technologies | 3 | Active |
| US7736846B2 | Methods of assaying for modulators of the inflammatory process using components of the ubiquitin ligation cascade | Physics | 3 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.